Sarcoma Drugs Strategic Industry Research Report 2023-2024 & 2030, Competitive Profiles of 42 Players Including Amgen, Bayer, Eisai, Eli Lilly, Johnson and Johnson, Novartis, Pfizer Inc.
December 03, 2024 08:48 ET
|
Research and Markets
Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Sarcoma Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Sarcoma Drugs was...
Europe Soft Tissue Sarcoma Market Report 2023: Growing Focus on Personalized Medicine Presents Opportunities
May 31, 2023 05:38 ET
|
Research and Markets
Dublin, May 31, 2023 (GLOBE NEWSWIRE) -- The "Europe Soft Tissue Sarcoma Market By Treatment (Targeted Therapy, Chemotherapy, Anti-Angiogenesis Drug, Radiation Therapy), By Disease Type, By End...
Global Soft Tissue Sarcoma Treatment Market Size/Share 2023 Estimated to Reach USD 3,704.27 Million By 2032, at 10.7% CAGR: Analysis by Polaris Market Research
March 20, 2023 09:41 ET
|
Polaris Market Research & Consulting LLP
New York, NY, March 20, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research has published a new research report titled “Soft Tissue Sarcoma Treatment Market Share, Size, Trends, Analysis, Industry...